Effects of hydrostatic pressure on the stability and thermostability of poliovirus: A new method for vaccine preservation

Vaccine

Volumn 27, Issue 39, 2009, Pages 5332-5337

  Ferreira, Evanilce ^a   Mendes, Ygara S ^b   Silva, Jerson L ^b   Galler, Ricardo ^a   Oliveira, Andréa C ^b   Freire, Marcos S ^a   Gaspar, Luciane P ^a  

^a Instituto de Technologia em Imunobiologicos   (Brazil)

^b Centro Nacional de Ressonancia Magnetica Nuclear de Macromoleculas   (Brazil)

Author keywords

Hydrostatic pressure; Poliovirus; Vaccine stability

Indexed keywords

POLIOMYELITIS VACCINE;

ANIMAL CELL; ARTICLE; DRUG STABILITY; DRUG STORAGE; FREEZING; HUMAN; HUMAN CELL; HYDROSTATIC PRESSURE; NONHUMAN; PICORNAVIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEROTYPE; THERMOSTABILITY; VIRUS INACTIVATION; VIRUS RESISTANCE;

ANIMALS; CERCOPITHECUS AETHIOPS; HOT TEMPERATURE; HUMANS; HYDROSTATIC PRESSURE; POLIOVIRUS; POLIOVIRUS VACCINES; PRESERVATION, BIOLOGICAL; VERO CELLS; VIRUS REPLICATION;

EID: 68349117194     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.099     Document Type: Article

References (38)

1. Wallis C., and Melnick J.L. Cationic stabilization: a new property of enteroviruses. Virology 16 (1962) 504-505
2. Sokhey J., Gupta C.K., Sharma B., and Singh H. Stability of oral polio vaccine at different temperatures. Vaccine 6 (1988) 12-13
3. Shiomi H., Urasawa T., and Urasawa S. Heat stability of the lyophilized Sabin polio vaccine. Jpn J Infect Dis 56 2 (2003) 70-72
4. Brown F. New approaches to stabilisation of vaccines potency: WHO Headquarters, Geneva, May 1995: 87 (developments in biological standardization) (1996), S Karger Publications
5. Melnick J.L., and Wallis C. Effects of pH on thermal stabilization of oral poliovirus vaccine by magnesium chloride. Proc Soc Exp Biol Med 112 (1963) 894-897
6. Melnick J.L., Ashkenazy A., Midulla V.C., Wallis C., and Bernstein A. Immunogenic potency of magnesium chloride-stabilized oral poliovaccine. JAMA 185 (1963) 406-408
7. Galazka A, Milstien J, Zaffran M. Thermostability of vaccines. Geneva: Global Programme for Vaccines and Immunization, World Health Organization WHO/EPI/GEN/89.08; 1989.
8. Melnick J.L. Live polio vaccine. In: Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., et al. (Eds). Virology. 3rd ed. (1996), Lippincott-Raven Publishers, New York 699-702
9. Rombaut B., Andries K., and Boeye A. Stabilisation of poliovirus with pirodavir. Dev Biol Stand 87 (1996) 173-180
10. 2O). Vaccine 12 (1995) 1058-1063
11. Silva J.L., Luan P., Glaser M., Voss E.W., and Weber G. Effects of hydrostatic pressure on a membrane-enveloped virus: high immunogenicity of the pressure-inactivated virus. J Virol 66 (1992) 2111-2117
12. Nakagami T., Shigehisa T., Ohmori T., Taji S., Hase A., Kimura T., et al. Inactivation of herpes viruses by high hydrostatic pressure. J Virol Methods 38 (1992) 255-261
13. Jurkiewicz E., Villas-Boas M., Silva J.L., Weber G., Hunsmann G., and Clegg R.M. Inactivation of simian immunodeficiency virus by hydrostatic pressure. Proc Natl Acad Sci USA 92 (1995) 6935-6937
14. Tian S.M., Qian J.F., Shao G.Q., and Ruan K.C. High immunogenicity of the pressure-inactivated virus. Acta Biochim Biophys Sin 31 (1999) 334-336
15. Masson P., Tonello C., and Balny C. High pressure biotechnology in medicine and pharmaceutical science. J Biomed Biotechnol 1 (2001) 85-88
16. Freitas T.R., Gaspar L.P., Caldas L.A., Silva J.L., and Rebello M.A. Inactivation of classical swine fever virus: association of hydrostatic pressure and ultraviolet irradiation. J Virol Methods 108 (2003) 205-211
17. Silva J.L., Foguel D., Suarez M., Gomes A.M.O., and Oliveira A.C. High-pressure applications in medicine and pharmacology. J Phys 16 (2004) S929-S944
18. Ishimaru D., Sá-Carvalho D., and Silva J.L. Pressure-inactivated FMDV: a potential vaccine. Vaccine 22 (2004) 2334-2339
19. Gaspar L.P., Mendes Y.S., Yamamura A.M., Almeida L.F., Caride E., Gonçalves R.B., et al. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development. J Virol Methods 150 (2008) 57-62
20. Oliveira A.C., Ishimaru D., Gonçalves R.B., Smith T.J., Mason P., Sa-Carvalho D., et al. Low temperature and pressure stability of picornaviruses: implications for virus uncoating. Biophys J 76 (1999) 1270-1279
21. Wilkinson N., Kurdziel A.S., Langton S., Needs E., and Cook N. Resistance of poliovirus to inactivation by high hydrostatic pressure. Innovative Food Sci Emerg Technol 2 (2001) 95-98
22. Kingsley D.H., Hoover D.G., Papafragkou E., and Richasds G.P. Inactivation of hepatitis A virus and a calicivirus by high hydrostatic pressure. J Food Prot 65 (2002) 1605-1609
23. Kingsley D.H., Chen H., and Hoover D.G. Inactivation of selected picornaviruses by high hydrostatic pressure. Virus Res 102 2 (2004) 221-224
24. Basset J., Lépine P., and Chaumont L. Effects of pressures of the poliomyelitis virus (Lansing strain). Ann Inst Pasteur 90 5 (1956) 575-593
25. Murchie L.W., Cruz-Romero M., Kerry J.P., Linton M., Patterson M.F., Smiddy M., et al. High pressure processing of shellfish: a review of microbiological and other quality aspects. Innovative Food Sci Emerg Technol 6 (2005) 257-270
26. Grove S.F., Forsyth S., Wan J., Coventry J., Cole M., Stewart C.M., et al. Inactivation of hepatitis A virus, poliovirus and a norovirus surrogate by high pressure processing. Innovative Food Sci Emerg Technol 9 (2008) 206-210
27. Reed L.J., and Muench H.A. A simple method of estimating fifty percent end points. Am J Hyg (1938) 493-497
28. Paladini A.A., and Weber G. Pressure-induced reversible dissociation of enolase. Biochemistry 20 (1981) 2587-2593
29. Dimmock N.J. Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures. Virology 31 2 (1967) 338-353
30. Rombaut B., Verheyden B., Andries K., and Boeyé A. Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation. J Virol 68 (1994) 6454-6457
31. Newman J.F.E., Tirrell C., Ullman C., Piatti P.G., and Brown F. Stabilising oral poliovacccine at high ambient temperatures. Vaccine 13 (1995) 1431-1435
32. Newman J.F.E., Tirrell C., Ullman C., Piatti P.G., and Brown F. Stabilising oral poliovacccine at high ambient temperatures. Dev Biol Stand 87 (1996) 155-160
33. Gaspar L.P., Johnson J.E., Silva J.L., and Da Poian A.T. Partially folded states of the capsid protein of cowpea severe mosaic vírus in the disassembly pathway. J Mol Biol 273 2 (1997) 456-466
34. Brown F., and Wild T.F. The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid. Biochim Biophys Acta 119 (1966) 301-308
35. 2. Arch Biochem Biophys 342 (1997) 108-116
36. Dorval B.L., Chow M., and Klibanov A.M. Lysine and other diamines dramatically stabilize poliovirus against thermoinactivation. Biotechnol Bioeng 35 (1990) 1051-1054
37. Yash P. Role of genetic factors in polio eradication: new challenge for policy makers. Vaccine 25 (2007) 8365-8371
38. Arya S.C. Stabilization of vaccines: to be or not to be. Vaccine 19 (2001) 595-597